Find policies, billing codes, payers, states, and providers
Home Hemodialysis (HHD) Coverage Criteria
Customize your policy alerts
Sign up for sierra health and life Policy 2026T0476Y alerts
Get alerted when Policy 2026T0476Y changes without checking for updates manually.
Monitor payer policy activity
Policy governing coverage and medical necessity criteria for home hemodialysis (with and without skilled care) as an alternative to facility-based hemodialysis for individuals with end-stage renal disease covered by the payer's commercial and individual exchange plans.
Template Update noted in policy history.
Coverage and Medical Necessity Criteria for Home Hemodialysis
HHD without skilled care
Covered when ALL of the following are met
From coverage rationale (chunks 3,7)
HHD with skilled care (staff-assisted)
Covered when ALL of the following are met
From coverage rationale (chunk 3)
Clinical evidence summary
See Ok et al. (2023), Weinhandl/Weinhandl et al., Miller et al., and FHN trials (chunks 18,21,27,30)
Evidence and Guideline-based considerations
Guidance and evidence highlights relevant to coverage decisions
Supported by Kasza et al. (chunk 36)
Supported by Piccoli et al. (chunks 36-37)
Supported by Ishani et al. and related reviews (chunk 37)
Supported by Slinin et al. and FHN trial reports (chunks 38,30)
Supported by NKF/KDOQI guideline statements (chunks 40,41)
Supported by AHA statement (chunk 39)
Supported by NICE guidance (chunk 42)
Individuals with complications or significant concomitant disease that would make home hemodialysis unsafe or unsuitable are excluded from coverage under standard HHD criteria. This includes patients who are not clinically stable on dialysis, those with active conditions that require skilled nursing or procedural interventions during treatments, and those lacking a well-functioning vascular access. Coverage requires demonstration that the patient and any non‑professional caregiver have the ability to perform and maintain HHD and have completed comprehensive training; absence of these conditions supports exclusion from HHD coverage.
Findings from the FHN Nocturnal Trial warrant caution: the trial did not demonstrate definitive benefit of nocturnal six‑times‑weekly home dialysis for the primary outcomes and secondary analyses suggested a trend toward increased vascular access events in the nocturnal arm. Extended follow‑up also identified an increased mortality signal in the nocturnal group, indicating that the survival implications of intensive nocturnal regimens remain uncertain and require further investigation before broadly endorsing nocturnal HHD.
The NKF/KDOQI work group reviewed the evidence and concluded that, owing to inconclusive efficacy data and potential for increased harm, no firm recommendation could be made in favor of routine home long frequent hemodialysis. The guideline statements emphasize that conventional in‑center HD remains the most common treatment and that evidence supporting home short frequent or long frequent HHD is insufficient to support broad endorsement.
Home hemodialysis is considered not medically necessary when the patient is clinically unstable on dialysis, requires skilled interventions during treatments, or lacks the training, ability, or an available caregiver to perform HHD safely. Lack of a well‑functioning vascular access is also a contraindication to HHD under the policy. In such cases, facility‑based dialysis is the appropriate setting.
The body of evidence for more frequent or longer-duration hemodialysis contains many limitations: overall quality is rated as low to very low for several critical outcomes, trial populations were often younger and healthier than the general dialysis population, and many studies were underpowered for mortality. Consequently, the magnitude and generalizability of benefits for frequent or extended HHD remain uncertain and require individualized justification.
Potential harms identified in randomized trials and systematic reviews include inconsistent improvement in key clinical outcomes and an increased frequency of vascular access procedures with more frequent or longer HD regimens. Some trials also failed to show mortality or left ventricular mass benefits, and the balance of modest physiologic improvements against procedural risks and uncertain effects on survival should be considered when selecting HHD schedules.
Applicable Procedure, Service, and Measurement Codes
| 90963 | End-stage renal disease (ESRD) related services for home dialysis per full month, for patients younger than 2 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents. |
| 90964 | End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 2-11 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents. |
| 90965 | End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 12-19 years of age to include monitoring for the adequacy of nutrition, assessment of growth and development, and counseling of parents. |
| 90966 | End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older. |
| 90967 | End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients younger than 2 years of age. |
| 90968 | End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients 2-11 years of age. |
| 90969 | End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients 12-19 years of age. |
| 90970 | End-stage renal disease (ESRD) related services for dialysis less than a full month of service, per day; for patients 20 years of age and older. |
| 90989 | Dialysis training, patient, including helper where applicable, any mode, completed course. |
| 90993 | Dialysis training, patient, including helper where applicable, any mode, course not completed, per training session. |
| No codes listed |
Provider Requirements, Prior Authorization, and Documentation
Prior authorization required for HHD services
Prior authorization is required for home hemodialysis services billed under the listed codes and coverage is contingent on meeting the policy's medical necessity criteria (stability on dialysis, completion of training, well‑functioning vascular access, and absence of contraindicating comorbidities). Submit PA requests using the applicable procedure/service codes: 90963–90970, 90989, 90993, 99512, and S9335.
- Coverage contingent on meeting medical necessity criteria: stable on dialysis; training completed; absence of unsafe comorbidities; well‑functioning vascular access.
- Use the listed CPT/HCPCS codes when requesting prior authorization.
Justify HHD modality and device use in PA
When requesting prior authorization that involves a specific HHD device or modality (e.g., Tablo system), include clinical justification and device‑specific training/support plans; clinical trial and device study reports cited in the evidence assessment are limited by small samples and short durations and should not substitute for case‑specific justification.
- Include indication, device model or system, and a description of training and support for patient/caregiver.
- Reference relevant trial/device study outcomes only as supporting evidence, not sole justification.
PA depends on member's benefit plan
Prior authorization requirements and the application of this policy depend on the member's specific benefit plan; verify and follow the member‑specific benefit document (and applicable federal/state mandates) before requesting authorization. This policy may be applied to Medicare Advantage in the absence of NCD/LCD guidance, per MAO rules.
- Check the member‑specific benefit plan document; in the event of conflict, the member plan governs.
- For Medicare Advantage members, confirm whether NCD/LCD exist; absent such guidance, MAO-level determinations may apply.
No step therapy required by policy
No formal step therapy sequence is specified in this policy; modality selection is determined by the attending nephrologist based on patient capability, contraindications, and individualized clinical judgment.
- Document clinical rationale for choosing HHD versus in‑center modalities when relevant to coverage decisions.
Consider home dialysis as step from in‑center care
Consider home dialysis as a clinically appropriate step from in‑center care when supported by multidisciplinary care and documented clinical benefit; systematic reviews associated home dialysis and multidisciplinary interventions with lower mortality and hospitalizations in observational studies.
- When transitioning from in‑center to home dialysis, document multidisciplinary supports (training, nursing/care coordination) and rationale tied to patient outcomes.
No explicit step therapy rules in policy
This document does not establish explicit step therapy rules or mandatory prior in‑center trial requirements for HHD; absence of such rules means clinical selection remains individualized.
- If a plan sponsor imposes step requirements, follow the member‑specific benefit plan terms.
Required clinical documentation for PA
Provide clinical documentation that supports the member is stable on dialysis, has completed or is enrolled in a dialysis training program (report CPT 90989 for completed course or 90993 per training session if incomplete), has a well‑functioning vascular access, and—when applicable—justifies the need for staff‑assisted (skilled) home hemodialysis.
Document patient characteristics and training
Document patient‑specific characteristics that influenced selection for HHD, including age, comorbidities, prior dialysis regimen, and demonstrated training capability, because many studies included younger or healthier participants and observational evidence is subject to selection bias.
- Record patient's age, comorbid conditions, prior in‑center dialysis experience, and caregiver availability/ability.
- Note any study limitations referenced when using literature to support the request.
Reference member‑specific benefit documents
When deciding coverage and preparing prior authorization documentation, reference the member‑specific benefit plan document and any applicable federal or state mandates; document which plan provisions or mandates were used in the decision.
- Specify the member plan name and relevant clauses relied upon in the PA submission.
- For Medicare Advantage members, note whether NCD/LCD exist or whether MAO rationale is being used.
Denial triggers if medical necessity not met
Claims or PA requests may be denied if the individual does not meet the medical necessity criteria for HHD—examples include being unstable on dialysis, requiring skilled interventions during treatments, lacking completed training or an available caregiver, having contraindicating comorbidities, or lacking a well‑functioning vascular access.
- Denials likely when documentation fails to show stability, training completion (or plan for training), adequate access, or absence of unsafe comorbidities.
- For staff‑assisted requests, justify why patient/caregiver cannot perform HHD and why leaving home is contraindicated.
Selection and documentation risks for HHD requests
Because observational studies may reflect selection of healthier or higher‑resource patients to HHD, failing to document clinical suitability and reasons for selecting HHD (versus patient preference alone) increases the risk of denial; include objective clinical measures and rationale to mitigate selection‑bias concerns.
- Provide objective measures (clinical stability, lab trends, access function) and explain why HHD is clinically appropriate for this patient.
- Avoid relying solely on cited cohort benefits without patient‑specific justification.
Member‑specific benefit plan governs coverage
Coverage determinations must follow the member‑specific benefit plan; if the member's plan terms conflict with this policy, the member‑specific benefit plan governs and failure to adhere to plan terms can lead to denial.
- Always verify and document the applicable member benefit provisions used to make the coverage determination.
- If uncertainty exists for Medicare Advantage members, document whether MAO rationale or NCD/LCD was applied.
Background on Hemodialysis and Home Hemodialysis
Hemodialysis (HD) is a form of renal replacement therapy that removes solutes and fluid by diffusion and ultrafiltration across an extracorporeal circuit. Conventional in‑center HD is typically provided three times per week for about three to five hours per session. Home hemodialysis (HHD) enables patients to receive HD at home using user‑friendly machines and may permit more frequent or longer sessions tailored to patient needs. Appropriate candidates for HHD are clinically stable on dialysis, have a well‑functioning vascular access (for example, an arteriovenous fistula is preferred), and possess the training and home support necessary to perform and maintain therapy safely.
Definitions and Key Terms
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.